Study of ASP1002 for adults with solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called ASP1002, alone or with other treatments, for people with advanced solid tumors that have stopped responding to standard therapies. It aims to see if ASP1002 can shrink tumors or slow their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of advanced solid tumor that cannot be removed with surgery or has spread to other parts of the body.
- You must have tried previous treatments that no longer work, or you cannot take them due to side effects.
- You must be able to provide a sample of your tumor tissue for testing.
- You must be in generally good health, with a performance status of 0 or 1 (able to care for yourself).
- You must not have certain medical conditions, like active autoimmune disease or heart problems.
- Women who could become pregnant and men with partners who could become pregnant must use effective birth control during and after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two new drugs, P1101 and P1801, in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the combination is safe and effective.
This study tests a new drug called SYS6043, alone or with other treatments, for advanced solid tumors that have not responded to standard therapy. It may offer a new option for patients with certain types of ovarian, fallopian tube, or primary peritoneal cancer.
This trial tests a new pill called ASN-3186 for people with advanced solid tumors that haven't responded to standard treatments. The drug may work especially well if your cancer has certain DNA repair problems, like a BRCA mutation.
This trial tests a new drug, ASP2998, given alone or with standard cancer treatments for people with advanced solid tumors, including certain types of lung, bladder, stomach, and breast cancers. The goal is to see if ASP2998 can help when other treatments have stopped working or are not an option.
This trial tests a new drug called ASP388B, given alone or with standard treatments, for people with certain advanced solid tumors that have stopped responding to therapy. It may help shrink tumors or slow their growth.
This trial tests a new investigational drug, BMS-986488, alone or with another drug (adagrasib), for people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and works against certain cancers.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.